16.99

2.10% -0.37

Biohaven Ltd (BHVN)

Overview News Price History Option Chain Financials Why BHVN Down? Discussions Forecast

Biohaven Ltd stock is traded at $16.99, with a volume of 301.32K. It is down -2.10% in the last 24 hours and up +25.98% over the past month. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Previous Close:

$17.36

Open:

$17.15

24h Volume:

301.32K

Relative Volume:

0.14

Market Cap:

$1.80B

Revenue:

Net Income/Loss:

$-766.97M

P/E Ratio:

-2.218

EPS:

-7.66

Net Cash Flow:

$-646.43M

1W Performance:

-1.36%

1M Performance:

+25.98%

6M Performance:

-9.02%

1Y Performance:

-66.98%

1-Day Range:

$16.87

$17.58

1-Week Range:

$14.83

$18.08

52-Week Range:

$12.79

$54.98

Biohaven Ltd Stock (BHVN) Company Profile

Name

Biohaven Ltd

Sector

Healthcare (1143)

Industry

Biotechnology (636)

Phone

203-404-0410

Address

215 CHURCH STREET, NEW HAVEN, CT

Employee

256

Twitter

@biohavenpharma

Next Earnings Date

2025-08-08

Latest SEC Filings

BHVN's Discussions on Twitter

Compare BHVN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BHVN Biohaven Ltd	16.99	1.76B	0	-766.97M	-646.43M	-7.66
VRTX Vertex Pharmaceuticals Inc	409.69	105.69B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	486.20	61.52B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	586.11	60.69B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	825.33	50.05B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.28	35.25B	4.56B	-176.77M	225.30M	-1.7177

Biohaven Ltd Stock (BHVN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-17-25	Initiated	Citigroup	Buy
Sep-03-25	Initiated	Raymond James	Strong Buy
May-19-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Feb-11-25	Initiated	Deutsche Bank	Buy
Sep-16-24	Initiated	Jefferies	Buy
Sep-04-24	Initiated	Bernstein	Outperform
Jul-24-24	Initiated	Morgan Stanley	Overweight
Feb-16-24	Initiated	RBC Capital Mkts	Outperform
Feb-06-24	Initiated	UBS	Buy
Dec-22-23	Initiated	H.C. Wainwright	Buy
Dec-08-23	Initiated	Robert W. Baird	Outperform
Jan-24-23	Initiated	SVB Securities	Outperform
Jan-04-23	Initiated	JP Morgan	Overweight
Dec-02-22	Initiated	BTIG Research	Buy
Oct-26-22	Upgrade	Cantor Fitzgerald	Neutral → Overweight
Oct-12-22	Initiated	Piper Sandler	Overweight
Aug-19-22	Downgrade	Piper Sandler	Overweight → Neutral
Aug-08-22	Downgrade	Wedbush	Outperform → Neutral
May-11-22	Downgrade	SVB Leerink	Outperform → Mkt Perform
Oct-19-21	Resumed	Morgan Stanley	Equal-Weight
Aug-10-21	Downgrade	UBS	Buy → Neutral
Aug-03-21	Reiterated	Canaccord Genuity	Buy
Mar-11-21	Initiated	UBS	Buy
Dec-15-20	Initiated	H.C. Wainwright	Buy
Apr-17-20	Initiated	Cowen	Outperform
Feb-10-20	Downgrade	Oppenheimer	Outperform → Perform
Feb-06-20	Initiated	Mizuho	Buy
Nov-22-19	Initiated	Wedbush	Outperform
Jun-25-19	Reiterated	Canaccord Genuity	Buy
May-06-19	Initiated	Goldman	Buy
Apr-09-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-04-19	Reiterated	Needham	Buy
Jul-03-18	Reiterated	Needham	Buy
Jul-02-18	Reiterated	Needham	Buy
Apr-05-18	Downgrade	Barclays	Overweight → Equal Weight
Feb-22-18	Reiterated	Canaccord Genuity	Buy
Dec-15-17	Initiated	Canaccord Genuity	Buy
Oct-03-17	Reiterated	Needham	Buy

View All

Biohaven Ltd Stock (BHVN) Latest News

Oct 15, 2025

Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platform - GlobeNewswire Inc.

Oct 15, 2025

Oct 14, 2025

Is Biohaven Ltd. stock a good choice for value investors2025 Market Sentiment & AI Driven Stock Movement Reports - newser.com

Oct 14, 2025

Biohaven Ltd. stock chart pattern explainedQuarterly Trade Summary & Weekly Sector Rotation Insights - newser.com

Oct 14, 2025

Regression analysis insights on Biohaven Ltd. performanceJuly 2025 Catalysts & Weekly Momentum Picks - newser.com

Oct 14, 2025

Oct 13, 2025

Will Biohaven Ltd. stock remain a Wall Street favoriteQuarterly Portfolio Summary & Community Consensus Trade Signals - newser.com

Oct 13, 2025

Biohaven Ltd. stock trend outlook and recovery pathMarket Risk Report & Smart Allocation Stock Tips - newser.com

Oct 13, 2025

Oct 12, 2025

Will Biohaven Ltd. stock pay special dividends2025 Retail Activity & Weekly High Momentum Picks - newser.com

Oct 12, 2025

Will Biohaven Ltd. see short term momentumQuarterly Risk Review & Low Risk High Reward Ideas - newser.com

Oct 12, 2025

Oct 11, 2025

How to recover losses in Biohaven Ltd. stockQuarterly Market Review & Weekly Return Optimization Plans - newser.com

Oct 11, 2025

Oct 10, 2025

Pfizer settles Biohaven kickback case with DOJ for $60M - MSN

Oct 10, 2025

Biohaven (NYSE:BHVN) Trading 7% HigherStill a Buy? - MarketBeat

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms "Sell (E+)" Rating for Biohaven (NYSE:BHVN) - MarketBeat

Oct 09, 2025

Leading vs lagging indicators on Biohaven Ltd. performanceWeekly Trade Review & Capital Protection Trading Alerts - newser.com

Oct 09, 2025

Will Biohaven Ltd. Common Shares stock outperform energy sector in 2025Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com

Oct 09, 2025

Oct 07, 2025

Should Biohaven's (BHVN) Accelerating Cash Burn and Shorter Runway Require Action From Investors? - simplywall.st

Oct 07, 2025

New Haven startup Bexorg uses donated brains to reshape drug discovery - Hartford Business Journal

Oct 07, 2025

Biohaven (NYSE:BHVN) Trading Down 4.6%Here's Why - MarketBeat

Oct 07, 2025